跳至主要内容
临床试验/IRCT20240215061020N1
IRCT20240215061020N1招募中3 期

Investigating the effect of curcumin capsules compared to placebo on fatty liver in patients with polycystic ovary syndrome, a randomized, double-blind clinical trial

The University of Tarbiat Modares0 个研究点目标入组 74 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
Female

入选标准

  • Women of reproductive age from 18 to 45 years old
  • Women with polycystic ovary syndrome and non-alcoholic fatty liver disease
  • Having two of the three Rotterdam criteria including: having polycystic ovary ultrasound view, having serum hyperandrogenism with/without clinical symptoms related to hyperandrogenism such as acne, hirsutism, acanthosis nigricans, etc., having disordered ovulation and irregular menstrual cycle.
  • Being able to speak and write in Farsi

排除标准

  • Breastfeeding
  • Using hormonal methods to prevent pregnancy
  • Having any other diagnosed disease
  • Being allergic to turmeric
  • History of advanced chronic liver disease
  • Use of tobacco and alcohol
  • Drug addiction
  • Adrenal hyperplasia that has symptoms similar to polycystic ovary syndrome
  • Renal failure or any other active digestive disorder
  • Non-metabolic chronic diseases
  • Thyroid disease
  • Hyperprolactinemia

研究者

发起方
The University of Tarbiat Modares

相似试验